Kopsavilkums
A peptide with very high specificity for the human melanocortin MC1 receptor identified by phage display was used as a lead for the design of new peptides. Two new peptides, MS05 and MS09, were synthesized and found to bind with sub-nanomolar affinities to the MC1 receptor. Both these peptides showed strong agonistic activity at the MC1 receptor. The MS05 was the most MC1 receptor selective as it showed virtually no binding affinity for the MC4 and MC5 receptors and only micromolar affinity for the MC3 receptor. The selectivity and potency of the new peptides make them potent tools for studies of MC1 receptors, as well as novel potential candidate drugs for the treatment of inflammatory conditions. Copyright (C) 2000 Elsevier Science Inc.
| Oriģinālvaloda | Angļu |
|---|---|
| Lapas (no-līdz) | 239-243 |
| Lapu skaits | 5 |
| Žurnāls | Peptides |
| Sējums | 21 |
| Izdevuma numurs | 2 |
| DOIs | |
| Publikācijas statuss | Publicēts - febr. 2000 |
| Ārēji publicēts | Jā |
ANO IAM
Šis izpildes rezultāts palīdz sasniegt šādus ANO ilgtspējīgas attīstības mērķus (IAM)
-
3. IAM — Laba Veselība un Labbūtība
Nospiedums
Uzziniet vairāk par pētniecības tēmām “New highly specific agonistic peptides for human melanocortin MC1 receptor”. Kopā tie veido unikālu nospiedumu.Citēt šo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver